We are constantly exposed to toxic chemicals that require metabolic activation to products responsible for cell injury. Cytochrome P450 2E1 has an important role in human health as a result of being induced by acute and chronic alcohol ingestion, catalyzing the bioactivation of many established carcinogens and hepatotoxins, and has been implicated as a causative factor in alcoholic liver disease. The activity of P450 2E1 depends on its concentration that is regulated by both the rate of synthesis and the rate of degradation. Studies have shown the importance of the degradative path in the regulation of P450 2E1 in adult liver. Despite this fact, little is known about the mechanism of enzyme loss. Our working hypothesis is that P450 2E1 undergoes degradation by both lysosomal and nonlysosomal pathways. the selectivity of the pathway is dictated by changes that occur in the structure of P450 2E1 as a result of labilization and these structural changes are recognized by cytosolic proteolytic systems. Cytosolic proteolysis represents the rapid degradation of the enzyme and its inhibition results in induction of the enzyme. The overall goal of this proposal is to characterize the pathways for P450 2E1 degradation and to determine how ethanol affects them. We are proposing a systematic investigation of the degradation of P450 2E1 using studies in vitro with microsomal suspensions and purified P450 2E1, studies in cells in culture with expressed P450 2E1, and studies in vivo after the induction of P450 2E1 by an acute dose of acetone as well as long term ethanol treatment. The proposal has four specific aims. 1. Characterize the damage that occurs during the labilization of P450 2E1 with CCI4, 3- amino-1,2,4-triazole (3AT), diethydithiocarbamate (DEDTC), and H2O2. This will be done with purified P450 2E1 and subsequent isolation of the modified protein and or peptides by HPLC and sequence analysis of modified proteins. We will look for heme-linked peptides and oxidatively damaged amino acids. 2. Characterize the degradation of P450 2E1 in vitro using purified components of the ubiquitin-dependent and the multicatalytic proteinase (MCP) pathways. Proteolysis with purified components of the ubiquitin-dependent and MCP pathways will be used in vitro with differentially modified forms of P450 2E1. This includes suicide inactivation, phosphorylation with protein kinase A (PKA), protein kinase C (PKC) and Ca+2-calmodulin dependent protein kinase (CaM kinase II), and enzyme modified by site directed mutagenesis and expressed E. coli. 3. Characterize the degradation of P450 2E1 after stable expression in Chinese Hamster Ovary (CHO-K1) cells. The full length P450 2E1 cDNA will be subcloned into expression vectors and transfected into CHO-K1 cells in culture. The half-life of the enzyme will be determined by pulse-chase experiments. Questions concerning the degradative pathway will be tested by using specific inhibitors and site-specific mutations of the enzyme. 4. Characterize the degradation of P450 2E1 in mice after an acute dose of acetone and in rats after chronic ethanol by enteral feeding. Affects of these treatments on the proteolytic systems identified in Aims 1, 2 and 3 will be determined. Together, the results from these studies will provide important information about the affect of ethanol on P450 2E1 degradation as well as the degradation of other proteins after ethanol treatment.

National Institute of Health (NIH)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Research Project (R01)
Project #
Application #
Study Section
Biochemistry, Physiology and Medicine Subcommittee (ALCB)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Oregon Health and Science University
Schools of Medicine
United States
Zip Code
Jones, Jeffrey P; Joswig-Jones, Carolyn A; Hebner, Michelle et al. (2011) The effects of nitrogen-heme-iron coordination on substrate affinities for cytochrome P450 2E1. Chem Biol Interact 193:50-6
Koop, Dennis R (2006) Alcohol metabolism's damaging effects on the cell: a focus on reactive oxygen generation by the enzyme cytochrome P450 2E1. Alcohol Res Health 29:274-80
DeBarber, Andrea E; Bleyle, Lisa A; Roullet, Jean-Baptiste O et al. (2004) Omega-hydroxylation of farnesol by mammalian cytochromes p450. Biochim Biophys Acta 1682:18-27
Huan, Jian-Ya; Streicher, John M; Bleyle, Lisa A et al. (2004) Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells. Toxicol Appl Pharmacol 199:332-43
Schattenberg, Jorn M; Wang, Yongjun; Rigoli, Raina M et al. (2004) CYP2E1 overexpression alters hepatocyte death from menadione and fatty acids by activation of ERK1/2 signaling. Hepatology 39:444-55
Isayama, Fuyumi; Froh, Matthias; Bradford, Blair U et al. (2003) The CYP inhibitor 1-aminobenzotriazole does not prevent oxidative stress associated with alcohol-induced liver injury in rats and mice. Free Radic Biol Med 35:1568-81
Spatzenegger, Margit; Liu, Hong; Wang, Qinmi et al. (2003) Analysis of differential substrate selectivities of CYP2B6 and CYP2E1 by site-directed mutagenesis and molecular modeling. J Pharmacol Exp Ther 304:477-87
Jones, Brett E; Liu, Hailing; Lo, Chau R et al. (2002) Cytochrome P450 2E1 expression induces hepatocyte resistance to cell death from oxidative stress. Antioxid Redox Signal 4:701-9
Wadsworth, T L; McDonald, T L; Koop, D R (2001) Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-alpha. Biochem Pharmacol 62:963-74
Wadsworth, T L; Koop, D R (2001) Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced release of nitric oxide. Chem Biol Interact 137:43-58

Showing the most recent 10 out of 31 publications